<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Carfilzomib Is Effective For Multiple Myeloma – Part 2: Treatment Of Specific Patient Groups (ASH 2009)</title>
	<atom:link href="http://www.myelomabeacon.com/news/2009/12/04/carfilzomib-is-effective-for-multiple-myeloma-%e2%80%93-part-2-treatment-of-specific-patient-groups-ash-2009/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.myelomabeacon.com/news/2009/12/04/carfilzomib-is-effective-for-multiple-myeloma-%e2%80%93-part-2-treatment-of-specific-patient-groups-ash-2009/</link>
	<description>The Myeloma Beacon provides extensive news, articles, and directories related to multiple myeloma. Its mission is to be the leading Internet resource for multiple myeloma patients, their families, and others interested in multiple myeloma.</description>
	<lastBuildDate>Fri, 30 Jul 2010 22:08:42 -0400</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
